Evidence map›Paper›PMID 21779761›Full record

ArticlePflugers Archiv : European journal of physiology2011

Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.

Angélica López-Izquierdo, Iván A Aréchiga-Figueroa, Eloy G Moreno-Galindo, Daniela Ponce-Balbuena, Martín Rodríguez-Martínez, Tania Ferrer-Villada, Aldo A Rodríguez-Menchaca, Marcel A G van der Heyden, José A Sánchez-Chapula

Abstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. The network of cardiac KNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  2. Article
  3. Article
  4. Development of IFrontiers in pharmacology · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Angélica López-IzquierdoUnidad de Investigación, Carlos Méndez del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Av. 25 de Julio 965, CP 28045, Colima, Colima, Mexico.
Iván A Aréchiga-Figueroa
Eloy G Moreno-Galindo
Daniela Ponce-Balbuena
Martín Rodríguez-Martínez
Tania Ferrer-Villada
Aldo A Rodríguez-Menchaca
Marcel A G van der Heyden
José A Sánchez-Chapula
Universidad de Colima · MXAutonomous University of San Luis Potosí · MXUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac inward rectifier potassium currents determine the resting membrane potential and contribute repolarization capacity during phase 3 repolarization. Quinacrine is a cationic amphiphilic drug. In this work, the effects of quinacrine were studied on cardiac Kir channels expressed in HEK 293 cells and on the inward rectifier potassium currents, I(K1) and I(KATP), in cardiac myocytes. We found that quinacrine differentially inhibited Kir channels, Kir6.2 ∼ Kir2.3 > Kir2.1. In addition, we found in cardiac myocytes that quinacrine inhibited I(KATP) > I(K1). We presented evidence that quinacrine displays a double action towards strong inward rectifier Kir2.x channels, i.e., direct pore block and interference in phosphatidylinositol 4,5-bisphosphate, PIP(2)-Kir channel interaction. Pore block is evident in Kir2.1 and 2.3 channels as rapid block; channel block involves residues E224 and E299 facing the cytoplasmic pore of Kir2.1. The interference of the drug with the interaction of Kir2.x and Kir6.2/SUR2A channels and PIP(2) is suggested from four sources of evidence: (1) Slow onset of current block when quinacrine is applied from either the inside or the outside of the channel. (2) Mutation of Kir2.3(I213L) and mutation of Kir6.2(C166S) increase their affinity for PIP(2) and lowers its sensitivity for quinacrine. (3) Mutations of Kir2.1(L222I and K182Q) which decreased its affinity for PIP(2) increased its sensitivity for quinacrine. (4) Co-application of quinacrine with PIP(2) lowers quinacrine-mediated current inhibition. In conclusion, our data demonstrate how an old drug provides insight into a dual a blocking mechanism of Kir carried inward rectifier channels.

Indexed as

HEK293 CellsHumansKcnj11 ChannelMyocytes, CardiacPhosphatidylinositol 4,5-DiphosphatePotassium Channels, Inwardly RectifyingQuinacrineKcnj11 ChannelKCNJ2 protein, humanKCNJ4 protein, humanPhosphatidylinositol 4,5-DiphosphatePotassium Channels, Inwardly RectifyingQuinacrine

Identifiers

PMID21779761
OpenAlexW2131584867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.